Ranolazine (monotherapy) vs placebo
AMI incidence · patients with stable angina pectoris
Ranolazine (monotherapy) showed no clear difference in AMI incidence compared with placebo (low certainty).
1 finding from 1 review
- RR 0.88 [0.69, 1.12]3 studies · 2983 participantsLow